VCBeat Health Contact Us
Home Hansoh Pharmaceutical (03692) Acquires 800,000 Shares Under Restricted Share Unit Plan

Hansoh Pharmaceutical (03692) Acquires 800,000 Shares Under Restricted Share Unit Plan

Jun 30, 2023 19:27 CST Updated 19:27
Hansoh Pharma

Pharmaceutical Research, Production, and Sales

Hansoh Pharma (03692) announced that during June 2023, it had purchased a total of 800,000 shares on the market under the Restricted Share Unit Plan. The average consideration per share was approximately HKD 12.5977.